Skip to main content
Premium Trial:

Request an Annual Quote

OpGen to Distribute Menarini Silicon Cellsearch Platform in North America for COVID-19 Applications

NEW YORK – OpGen announced Monday it has inked a partnership with Menarini Silicon Biosystems to distribute and promote Menarini Silicon's Cellsearch Circulating Endothelial Cell (CEC) Kit in North America.

Financial and other terms of the deal were not disclosed.

Under the agreement, OpGen will market and sell Menarini Silicon's Cellsearch platform, CEC kit, and other COVID-19 related products in North America. The platform is for research use only, and is intended to enrich and enumerate CECs from whole blood, which is useful in studying the progression of COVID-19 and could help identify patients at risk of severe complications, OpGen said in a statement.

Both OpGen and Menarini Silicon said they intend to expand their portfolios of COVID-19 products and platforms, which OpGen will distribute commercially to infectious disease hospitals, labs, research centers, and other COVID-19 testing facilities. Bologna, Italy-based Menarini Silicon is a subsidiary of the multinational Menarini Group.

A. Menarini Diagnostics, the European diagnostics division of the Menarini Group, also has a strategic distribution partnership with OpGen subsidiary Curetis for products including its Unyvero platform in Europe, which has been in place since 2019.

Last month, Menarini Silicon said it will sell Healgen Scientific's rapid antibody detection kit for SARS-CoV-2 IgG and IgM antibodies in the US.

The Scan

Study Links Evolution of Longevity, Social Organization in Mammals

With the help of comparative phylogenetics and transcriptomics, researchers in Nature Communications see ties between lifespan and social organization in mammals.

Tumor Microenvironment Immune Score Provides Immunotherapy Response, Prognostic Insights

Using multiple in situ analyses and RNA sequence data, researchers in eBioMedicine have developed a score associated with immunotherapy response or survival.

CRISPR-Based Method for Finding Cancer-Associated Exosomal MicroRNAs in Blood

A team from China presents in ACS Sensors a liposome-mediated membrane fusion strategy for detecting miRNAs carried in exosomes in the blood with a CRISPR-mediated reporter system.

Drug Response Variants May Be Distinct in Somatic, Germline Samples

Based on variants from across 21 drug response genes, researchers in The Pharmacogenomics Journal suspect that tumor-only DNA sequences may miss drug response clues found in the germline.